---
$id: https://graph.org.ai/products/commodity/51151625
$type: Product
source: UNSPSC
code: "51151625"
title: "Butylscopolamine"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butylscopolamine

**UNSPSC Code**: 51151625
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C21H30NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Z3E1OF81V, chemically known as 3-oxa-9-azonitricyclo(3.3.1.0(2,4))nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, (7(s)-(1alpha,2beta,4beta,5alpha,7beta))- but generally known as butylscopolamine, which bears US NIH Compound Identifier 160883. Butylscopolamine most often comes in base and bromide forms. European Medicines Agency schedules Butylscopolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20624. World Health Organization schedules butylscopolamine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, BUTYLSCOPOLAMINE remains the US FDA Preferred Term for this commodity. Butylscopolamine bears US NLM identifiers UMLS ID C2827093 and NCI Concept Code C83571. SMILES: O1C2C3[N](C(C12)CC(OC(=O)C(CO)C1CCCCC1)C3)(CCCC)C. .

